Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Molecular Assay Technologies, Non-molecular Assay Technologies); End User (Hospitals, Research Institutes, Others)

Report Code: TIPRE00021578 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Get Free Sample PDF
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Human leukocyte antigens play an essential part in the body's immune response to external substances. The principal use for human leukocyte antigen (HLA) testing is to match organ and tissue transplant recipients with compatible donors. HLA testing also involves screening transplant recipients for the presence of antibodies that might target the donated tissue or organ as part of an immune response.

MARKET DYNAMICS

The human leukocyte antigen testing market is driving due to continuous focus on improving the human leukocyte antigen testing, increasing funding and research activities are growing its demand. However, the high cost of human leukocyte antigen testing will hamper its growth. Moreover, a high level of awareness among citizens, increased adoption of advanced technology are expected to provide opportunities in the global human leukocyte antigen testing market.

MARKET SCOPE

The "Human Leukocyte Antigen Testing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of human leukocyte antigen testing market with detailed market segmentation by type and end user. The human leukocyte antigen testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in human leukocyte antigen testing market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The human leukocyte antigen testing market is segmented based on type and end user. Based on type, the market is segmented into molecular assay technologies and non-molecular assay technologies. Based on end user, the market is segmented as hospitals, research institutes, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Human Leukocyte Antigen Testing market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Human Leukocyte Antigen Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Human Leukocyte Antigen Testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Human Leukocyte Antigen Testing market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Human Leukocyte Antigen Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Human Leukocyte Antigen Testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for Human Leukocyte Antigen Testing in the global market. Below mentioned is the list of few companies engaged in the Human Leukocyte Antigen Testing market.

The report also includes the profiles of key players in Human Leukocyte Antigen Testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Thermo Fisher Scientific
  •   GenDx
  •   F. Hoffmann-La Roche
  •   QIAGEN N.V.
  •   Illumina
  •   Bio-Rad Laboratories
  •   BD
  •   Immucor
  •   Hologic
  •   CareDx

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Human Leukocyte Antigen (HLA) Testing Market - By Type
1.3.2 Human Leukocyte Antigen (HLA) Testing Market - By End User
1.3.3 Human Leukocyte Antigen (HLA) Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HUMAN LEUKOCYTE ANTIGEN (HLA) TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HUMAN LEUKOCYTE ANTIGEN (HLA) TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HUMAN LEUKOCYTE ANTIGEN (HLA) TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. HUMAN LEUKOCYTE ANTIGEN (HLA) TESTING - GLOBAL MARKET OVERVIEW
6.2. HUMAN LEUKOCYTE ANTIGEN (HLA) TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HUMAN LEUKOCYTE ANTIGEN (HLA) TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MOLECULAR ASSAY TECHNOLOGIES
7.3.1. Overview
7.3.2. Molecular Assay Technologies Market Forecast and Analysis
7.4. NON-MOLECULAR ASSAY TECHNOLOGIES
7.4.1. Overview
7.4.2. Non-molecular Assay Technologies Market Forecast and Analysis
8. HUMAN LEUKOCYTE ANTIGEN (HLA) TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. RESEARCH INSTITUTES
8.4.1. Overview
8.4.2. Research Institutes Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. HUMAN LEUKOCYTE ANTIGEN (HLA) TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Human Leukocyte Antigen (HLA) Testing Market Overview
9.1.2 North America Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis
9.1.3 North America Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By Type
9.1.4 North America Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By End User
9.1.5 North America Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Human Leukocyte Antigen (HLA) Testing Market
9.1.5.1.1 United States Human Leukocyte Antigen (HLA) Testing Market by Type
9.1.5.1.2 United States Human Leukocyte Antigen (HLA) Testing Market by End User
9.1.5.2 Canada Human Leukocyte Antigen (HLA) Testing Market
9.1.5.2.1 Canada Human Leukocyte Antigen (HLA) Testing Market by Type
9.1.5.2.2 Canada Human Leukocyte Antigen (HLA) Testing Market by End User
9.1.5.3 Mexico Human Leukocyte Antigen (HLA) Testing Market
9.1.5.3.1 Mexico Human Leukocyte Antigen (HLA) Testing Market by Type
9.1.5.3.2 Mexico Human Leukocyte Antigen (HLA) Testing Market by End User
9.2. EUROPE
9.2.1 Europe Human Leukocyte Antigen (HLA) Testing Market Overview
9.2.2 Europe Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis
9.2.3 Europe Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By Type
9.2.4 Europe Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By End User
9.2.5 Europe Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Human Leukocyte Antigen (HLA) Testing Market
9.2.5.1.1 Germany Human Leukocyte Antigen (HLA) Testing Market by Type
9.2.5.1.2 Germany Human Leukocyte Antigen (HLA) Testing Market by End User
9.2.5.2 France Human Leukocyte Antigen (HLA) Testing Market
9.2.5.2.1 France Human Leukocyte Antigen (HLA) Testing Market by Type
9.2.5.2.2 France Human Leukocyte Antigen (HLA) Testing Market by End User
9.2.5.3 Italy Human Leukocyte Antigen (HLA) Testing Market
9.2.5.3.1 Italy Human Leukocyte Antigen (HLA) Testing Market by Type
9.2.5.3.2 Italy Human Leukocyte Antigen (HLA) Testing Market by End User
9.2.5.4 Spain Human Leukocyte Antigen (HLA) Testing Market
9.2.5.4.1 Spain Human Leukocyte Antigen (HLA) Testing Market by Type
9.2.5.4.2 Spain Human Leukocyte Antigen (HLA) Testing Market by End User
9.2.5.5 United Kingdom Human Leukocyte Antigen (HLA) Testing Market
9.2.5.5.1 United Kingdom Human Leukocyte Antigen (HLA) Testing Market by Type
9.2.5.5.2 United Kingdom Human Leukocyte Antigen (HLA) Testing Market by End User
9.2.5.6 Rest of Europe Human Leukocyte Antigen (HLA) Testing Market
9.2.5.6.1 Rest of Europe Human Leukocyte Antigen (HLA) Testing Market by Type
9.2.5.6.2 Rest of Europe Human Leukocyte Antigen (HLA) Testing Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Overview
9.3.2 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Human Leukocyte Antigen (HLA) Testing Market
9.3.5.1.1 Australia Human Leukocyte Antigen (HLA) Testing Market by Type
9.3.5.1.2 Australia Human Leukocyte Antigen (HLA) Testing Market by End User
9.3.5.2 China Human Leukocyte Antigen (HLA) Testing Market
9.3.5.2.1 China Human Leukocyte Antigen (HLA) Testing Market by Type
9.3.5.2.2 China Human Leukocyte Antigen (HLA) Testing Market by End User
9.3.5.3 India Human Leukocyte Antigen (HLA) Testing Market
9.3.5.3.1 India Human Leukocyte Antigen (HLA) Testing Market by Type
9.3.5.3.2 India Human Leukocyte Antigen (HLA) Testing Market by End User
9.3.5.4 Japan Human Leukocyte Antigen (HLA) Testing Market
9.3.5.4.1 Japan Human Leukocyte Antigen (HLA) Testing Market by Type
9.3.5.4.2 Japan Human Leukocyte Antigen (HLA) Testing Market by End User
9.3.5.5 South Korea Human Leukocyte Antigen (HLA) Testing Market
9.3.5.5.1 South Korea Human Leukocyte Antigen (HLA) Testing Market by Type
9.3.5.5.2 South Korea Human Leukocyte Antigen (HLA) Testing Market by End User
9.3.5.6 Rest of Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market
9.3.5.6.1 Rest of Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market by Type
9.3.5.6.2 Rest of Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Overview
9.4.2 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Human Leukocyte Antigen (HLA) Testing Market
9.4.5.1.1 South Africa Human Leukocyte Antigen (HLA) Testing Market by Type
9.4.5.1.2 South Africa Human Leukocyte Antigen (HLA) Testing Market by End User
9.4.5.2 Saudi Arabia Human Leukocyte Antigen (HLA) Testing Market
9.4.5.2.1 Saudi Arabia Human Leukocyte Antigen (HLA) Testing Market by Type
9.4.5.2.2 Saudi Arabia Human Leukocyte Antigen (HLA) Testing Market by End User
9.4.5.3 U.A.E Human Leukocyte Antigen (HLA) Testing Market
9.4.5.3.1 U.A.E Human Leukocyte Antigen (HLA) Testing Market by Type
9.4.5.3.2 U.A.E Human Leukocyte Antigen (HLA) Testing Market by End User
9.4.5.4 Rest of Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market
9.4.5.4.1 Rest of Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market by Type
9.4.5.4.2 Rest of Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Human Leukocyte Antigen (HLA) Testing Market Overview
9.5.2 South and Central America Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis
9.5.3 South and Central America Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By Type
9.5.4 South and Central America Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By End User
9.5.5 South and Central America Human Leukocyte Antigen (HLA) Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Human Leukocyte Antigen (HLA) Testing Market
9.5.5.1.1 Brazil Human Leukocyte Antigen (HLA) Testing Market by Type
9.5.5.1.2 Brazil Human Leukocyte Antigen (HLA) Testing Market by End User
9.5.5.2 Argentina Human Leukocyte Antigen (HLA) Testing Market
9.5.5.2.1 Argentina Human Leukocyte Antigen (HLA) Testing Market by Type
9.5.5.2.2 Argentina Human Leukocyte Antigen (HLA) Testing Market by End User
9.5.5.3 Rest of South and Central America Human Leukocyte Antigen (HLA) Testing Market
9.5.5.3.1 Rest of South and Central America Human Leukocyte Antigen (HLA) Testing Market by Type
9.5.5.3.2 Rest of South and Central America Human Leukocyte Antigen (HLA) Testing Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HUMAN LEUKOCYTE ANTIGEN (HLA) TESTING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HUMAN LEUKOCYTE ANTIGEN (HLA) TESTING MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENDX
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. QIAGEN N.V.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ILLUMINA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIO-RAD LABORATORIES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. IMMUCOR
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. HOLOGIC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CAREDX
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Thermo Fisher Scientific
2. GenDx
3. F. Hoffmann-La Roche
4. QIAGEN N.V.
5. Illumina
6. Bio-Rad Laboratories
7. BD
8. Immucor
9. Hologic
10. CareDx
11. Biofortuna
12. Labcorp
13. Mylab Discovery
14. BAG Diagnostics GmbH
15. ACON LABS INC.
TIPRE00021578
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking